Swiss National Bank Optimize Rx Corp Transaction History

Swiss National Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$13.77 - $22.04 $19,278 - $30,856	1,400 Added 3.7%	39,200 $658,000
Q1 2022 May 09, 2022	BUY	$35.27 - $62.91 $102,283 - $182,439	2,900 Added 8.31%	37,800 $1.43 Million
Q4 2021 Feb 08, 2022	BUY	$53.57 - $98.0 $32,142 - $58,800	600 Added 1.75%	34,900 $2.17 Million
Q3 2021 Nov 08, 2021	BUY	$50.93 - $85.55 $76,395 - $128,325	1,500 Added 4.57%	34,300 $2.93 Million
Q2 2021 Aug 06, 2021	BUY	$42.76 - $63.33 $1.4 Million - $2.08 Million	32,800 New	32,800 $2.03 Million

101

12.9M

18.6K

1.1K

Ticker OPRX
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 18,023,100
Market Cap $180M
Description
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patien...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.